Document is current
Any future updates will be listed below
-
Authors
Outtier, An
Ferrante, Marc
- License Information
-
More Information
Article History
Received: 28 October 2024
Accepted: 20 November 2024
First Online: 4 December 2024
Declarations
:
: An Outtier shares no conflict of interest. Marc Ferrante—Research support: AbbVie, Amgen, Biogen, Janssen, Pfizer, Takeda and Viatris—Speaker’s fees: AbbVie, Amgen, Biogen, Boehringer Ingelheim, Falk, Ferring, Janssen-Cilag, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda, and Truvion Healthcare—Consultancy fees: AbbVie, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Janssen-Cilag, Medtronic, MSD, Pfizer, Samsung Bioepis, Sandoz, Regeneron, Takeda, and Thermo Fisher.
Free to read: This content has been made available to all.
